Desktop Site
|
19 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,088.33
+599.34
+0.83 %
Corporate Announcement
Security Code
500124
Company
Dr Reddys Laboratories Ltd
Exchange Disseminated Time
Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-oncology and Precision Oncology Targets |
1/22/2015 3:46:15 PM
Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated January 21, 2015, titled "Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-oncology and Precision Oncology Targets".
<< Back
Recently Viewed